Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: An analysis of 31 cases with confocal laser scanning microscopy

被引:104
作者
Favia, G. [1 ]
Pilolli, G. P. [1 ]
Maiorano, E. [2 ]
机构
[1] Univ Bari, Dept Dent Sci & Surg, I-70124 Bari, Italy
[2] Univ Bari, Dept Pathol Anat, I-70124 Bari, Italy
关键词
Bisphosphonates; Jawbones; Bone necrosis; Osteoporosis; Histomorphometry; BONE HISTOMORPHOMETRY; AVASCULAR NECROSIS; ZOLEDRONIC ACID; ALENDRONATE; PROSTATE; INHIBIT; BREAST; SAFETY; OSTEOMYELITIS; ANGIOGENESIS;
D O I
10.1016/j.bone.2009.05.008
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Introduction: Patients undergoing bisphosphonate therapies may develop jaw lesions, mainly consisting in bone necrosis. No effective treatment has been proposed so far for such lesions, nor is there a uniform concept on the possible pathogenesis of this entity. Methods: The study population included 31 patients with bisphosphonate-related osteonecrosis of the jaws and 10 healthy donors. All patients underwent to jaw bone biopsy and the tissue samples were divided into two parts, one of which was fixed, decalcified and routinely processed. The second part was fixed, embedded in methylmetacrylate, cut and stained with methylene blue and basic fuchsine. All samples were subjected to light and confocal microscopic examination and to histomorphometric analyses to evaluate differences in bone structure between the two samples groups. Results: Three main histological patterns were identified in ONJ patients: 1 - Areas with active acute inflammation, characterized by predominance of soft tissues, inflammatory infiltrate, acellular necrotic debris, thin-walled and dilated blood vessel, intensely basophilic bone spiculae with scalloped borders showing prominent bone resorption. 2 - Areas characterized by predominance of bony structures showing wide acellular necrotic sequestra and large, scalloped Haversian canals containing inflammatory cells. 3 Non-necrotic areas contained larger amounts of bone, showing increased trabecular thickness, inter-osteonic bone deposition and smaller and fewer Haversian canals, These differences were more evident after comparing the histomorphometrical data of samples from ONJ patients with controls. Also, lamellar bone from treated patients was composed of bigger osteones containing larger osteocytes. Two different types of newly-formed woven bone, mainly showing centrifugal spatial orientation, were easily detectable in these areas. Osteoclast-like cells detected in inflammatory areas from treated patients were small and contained few nuclei, but they were rare to absent in non-necrotic bone from the same patients. Conclusions: These features point at a peculiar process of bone remodeling in patients undergoing bisphosphonate therapy, which showed scarce osteoclastic activity and subsequent deposition of newly-formed bone. The latter would be made up of thicker bone structures supplied by fewer blood vessels. Consequently, in case of increased metabolic requests, this modified bone would not be supported by adequate blood supply, thus leading to necrosis and superinfection. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:406 / 413
页数:8
相关论文
共 54 条
[1]
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients [J].
Ali, SM ;
Esteva, FJ ;
Hortobagyi, G ;
Harvey, H ;
Seaman, J ;
Knight, R ;
Costa, L ;
Lipton, A .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) :3434-3437
[2]
*AM DENT ASS COUNC, 2006, J AM DENT ASSOC, V137, P1144
[3]
Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases [J].
Bagan, JV ;
Murillo, J ;
Jimenez, Y ;
Poveda, R ;
Milian, MA ;
Sanchis, JM ;
Silvestre, FJ ;
Scully, C .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2005, 34 (02) :120-123
[4]
Osteomyelitis of the maxilla secondary to osteopetrosis: Report of a case [J].
Barry, CP ;
Ryan, CD .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 2003, 95 (01) :12-15
[5]
Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology [J].
Bedogni, Alberto ;
Blandamura, Stella ;
Lokmic, Zerina ;
Palumbo, Carla ;
Ragazzo, Mirko ;
Ferrari, Francesca ;
Tregnaghi, Alberto ;
Pietrogrande, Francesco ;
Procopio, Olindo ;
Saia, Giorgia ;
Ferretti, Marzia ;
Bedogni, Giorgio ;
Chiarini, Luigi ;
Ferronato, Giuseppe ;
Ninfo, Vito ;
Russo, Lucio Lo ;
Lo Muzio, Lorenzo ;
Nocini, Pier Francesco .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2008, 105 (03) :358-364
[6]
Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells [J].
Boanini, Elisa ;
Torricelli, Paola ;
Gazzano, Massimo ;
Giardino, Roberto ;
Bigi, Adriana .
BIOMATERIALS, 2008, 29 (07) :790-796
[7]
Boissier S, 2000, CANCER RES, V60, P2949
[8]
Boissier S, 1997, CANCER RES, V57, P3890
[9]
Ten years' experience with alendronate for osteoporosis in postmenopausal women [J].
Bone, HG ;
Hosking, D ;
Devogelaer, J ;
Tucci, JR ;
Emkey, RD ;
Tonino, RP ;
Rodriguez-Portales, JA ;
Downs, RW ;
Gupta, J ;
Santora, AC ;
Liberman, UA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1189-1199
[10]
Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis [J].
Chavassieux, PM ;
Arlot, ME ;
Reda, C ;
Wei, L ;
Yates, AJ ;
Meunier, PJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1475-1480